Product

Cataflam

Aliases

Cataflam® 50 coated tablet

Name

CATAFLAM

INN Name

diclofenac potassium

FDA Approved

Yes

1 clinical trial

1 organization

3 indications

1 document

Indication

Non-steroidal Anti-inflammatory (NSAID)

Indication

Indication

Clinical trial

Randomized,Fully-replicated,Single Oral Dose,Open-label,Crossover BE Study to Compare Diclofenac Potassium Coated Tablet (50 mg Diclofenac Potassium) Versus Cataflam® 50 Coated Tablet (50 mg Diclofenac Potassium) in Healthy Subjects in Fasting State

Status: Completed, Estimated PCD: 2020-09-16

Document

DailyMed Label: CATAFLAM

Organization

BLUCREST PHARMACEUTICALS, LLC